Faculty who have authored publication Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study.
Name | Title | Department | Institution |
---|---|---|---|
Mehdi H. Hamadani MD | Professor | Medicine | Medical College of Wisconsin |
Parameswaran Hari MD | Adjunct Professor | Medicine | Medical College of Wisconsin |